Chiappella, Annalisa
https://orcid.org/0000-0002-2977-0098
Mayo Clinic
Fondazione IRCCS Istituto Nazionale dei Tumori
Citations 16
Randomized, phase III trial of the efficacy and safety of lenalidomide plus R-CHOP vs R-CHOP in patients with untreated ABC-type diffuse large B-cell lymphoma.
Nowakowski, Grzegorz S. , Zhang, Lei , Flament, Jocelyne, Repici, Jacqueline, Chiappella, Annalisa , Witzig, Thomas E. , Spina, Michele , Vitolo, Umberto
Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS8600-TPS8600
Feasibility of real-time cell-of-origin subtype identification by gene expression profile in the phase 3 trial of lenalidomide plus R-CHOP vs placebo plus R-CHOP in patients with untreated ABC-type diffuse large B-cell lymphoma (ROBUST).
Nowakowski, Grzegorz S. , Chiappella, Annalisa , Spina, Michele , Gascoyne, Randy D. , Zhang, Lei , Flament, Jocelyne, Repici, Jacqueline, Conlin, Erin, Delissio, Krista, Witzig, Thomas E. , Vitolo, Umberto
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7538-7538
Long term follow-up (FU) of lenalidomide plus R-CHOP therapy in patients with newly diagnosed diffuse large b-cell lymphoma (DLBCL): Combined analysis from two phase 2 trials.
Castellino, Alessia , LaPlant, Betsy, Pederson, Levi , Chiappella, Annalisa , Macon, William R. , King, Rebecca L. , Congiu, Angela Giovanna, Nowakowski, Grzegorz S. , Gaïdano, Gianluca , Tucci, Alessandra , Witzig, Thomas E. , Vitolo, Umberto
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 7562-7562
Results of real-time cell-of-origin subtype identification by gene expression profiling in patients with ABC-type diffuse large B-cell lymphoma in the phase III trial of lenalidomide plus R-CHOP vs placebo plus R-CHOP (ROBUST).
Nowakowski, Grzegorz S. , Chiappella, Annalisa , Spina, Michele , Gascoyne, Randy D. , Russo, Jacqueline, Kang, Janet, Zhang, Jingshan , Xu, Yingyong, investigators, on behalf of the ROBUST study, Witzig, Thomas E. , Scott, David W. , Zhang, Lei , Vitolo, Umberto , investigators, on behalf of the ROBUST study
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 7548-7548
ROBUST: PHASE III RANDOMIZED STUDY OF LENALIDOMIDE/R‐CHOP VS PLACEBO/R‐CHOP IN UNTREATED ABC‐TYPE DIFFUSE LARGE B‐CELL LYMPHOMA AND FEASIBILITY OF CELL OF ORIGIN SUBTYPING
Gascoyne, Randy D. , Russo, Jacqueline, Amoroso, Barbara, Hudak, Krista, Ogunkanmi, A., Xu, Yinyan , Ruiz, Wanda, Singh, Shailesh , Nowakowski, Grzegorz S. , Chiappella, Annalisa , Witzig, Thomas E. , Vitolo, Umberto , Singh, S.
Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 419-419
ROBUST: Lenalidomide-R-Chop Versus Placebo-R-Chop in Previously Untreated Abc-Type Diffuse Large B-Cell Lymphoma
Nowakowski, Grzegorz S. , Chiappella, Annalisa , Spina, Michele , Gascoyne, Randy D. , Zhang, Lei , Flament, Jocelyne, Repici, Jacqueline, Vitolo, Umberto , Witzig, Thomas E. , Vitolo, Umberto
Future Oncology | April 18, 2016 | Volume: 12 | Issue: 13 | Pages: 1553-1563